Paliperidone Palmitate-Induced Delirium in an Adolescent with Schizophrenia: Case report
- PMID: 30210852
- PMCID: PMC6132512
- DOI: 10.18295/squmj.2018.18.02.014
Paliperidone Palmitate-Induced Delirium in an Adolescent with Schizophrenia: Case report
Abstract
Schizophrenia is a serious long-term mental disorder which usually presents in adolescence or early adulthood. However, poor adherence to oral antipsychotics can lead to relapse and rehospitalisation. We report an adolescent male with schizophrenia who was referred to the South London & Maudsley National Health Service Foundation Trust, London, UK, in 2015 due to worsening psychotic symptoms. Following poor compliance with oral medications, a four-week regimen of paliperidone palmitate long-acting injections was initiated, with an initial positive response. However, 10 days after the second dose, the patient developed severe acute-onset delirium with fluctuating levels of consciousness. Paliperidone palmitate was discontinued and the patient instead underwent a course of zuclopenthixol decanoate long-acting injections with a favourable outcome.
Keywords: Adolescent Psychiatry; Antipsychotic Agents; Case Report; Delirium; Paliperidone Palmitate; Schizophrenia; United Kingdom; Zuclopenthixol.
References
-
- World Health Organisation. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical descriptions and diagnostic guidelines - Tenth revision of the International Statistical Classification of Diseases and Related Health Problems. [Accessed: Jan 2018]. From http://apps.who.int/iris/handle/10665/37958.
-
- Taylor D, Paton C, Kapur S. The Maudsley Prescribing Guidelines in Psychiatry. 12th ed. Hoboken, New Jersey, USA: Wiley-Blackwell; 2015. Children and adolescents; pp. 353–408.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical